Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLamanna, Anthony-
dc.contributor.authorMaingard, Julian-
dc.contributor.authorKok, Hong Kuan-
dc.contributor.authorBarras, Christen-
dc.contributor.authorJhamb, Ashu-
dc.contributor.authorThijs, Vincent N-
dc.contributor.authorChandra, Ronil-
dc.contributor.authorBrooks, Duncan Mark-
dc.contributor.authorAsadi, Hamed-
dc.identifier.citationWorld neurosurgery 2019; online first: 8 April-
dc.description.abstractCarotid artery stenting (CAS) is an established treatment for carotid artery stenosis, typically in a semi-elective or elective setting. The growth of mechanical thrombectomy for acute stroke has led to an increased use of emergent carotid artery stenting (eCAS). This single-centre retrospective case series evaluates the safety and efficacy of eCAS using a dual-layer micromesh nitinol stent to treat carotid artery stenosis in the acute stroke setting. Ethics approval was granted by the institutional review board. Clinical data of all patients who underwent CAS using the Casper dual-layer micromesh nitinol stent system (Microvention, Terumo, Tustin, CA, USA) at a tertiary level 24-hour endovascular thrombectomy service over a two-year period (June 2016-June 2018) were retrospectively obtained and reviewed. Twenty eCAS procedures were performed in nineteen patients over the study period. Most patients had tandem lesions (12/20; 60%). Median NIHSS score on admission was 17 (IQR 9-22). Stent deployment was technically successful in all patients. Recanalization rate was 95%. Symptomatic intracranial haemorrhage occurred in two patients (10%), both resulting in death. No other procedure-related deaths occurred. Stent thrombosis occurred in two patients. One delayed embolic stroke occurred. No other stent-related complications occurred. Median NIHSS score at 24 hours postprocedure was 3 (IQR 1-12). Six patients had a good clinical outcome (modified Rankin scale between 0-2) at 3-6 month follow up (38%). eCAS using the Casper stenting system is effective and technically feasible in the acute stroke setting, although the ideal antiplatelet and anticoagulation regime is not clearly established.-
dc.subjectCasper stent-
dc.subjectcarotid artery atherosclerosis-
dc.subjectcarotid artery stenosis-
dc.subjectcarotid artery stenting-
dc.titleCarotid artery stenting in acute stroke using a microporous stent device: a single centre experience.-
dc.typeJournal Article-
dc.identifier.journaltitleWorld neurosurgery-
dc.identifier.affiliationThe University of Melbourne, Melbourne, Australiaen
dc.identifier.affiliationInterventional Neuroradiology Unit - Monash Imaging, Monash Health, Melbourne, Australiaen
dc.identifier.affiliationInterventional Radiology Service, Department of Radiology, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Radiology, St Vincent's Hospital, Melbourne, Australiaen
dc.identifier.affiliationDepartment of Neurology, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Imaging - Monash Health, Melbourne, Australiaen
dc.identifier.affiliationInterventional Neuroradiology Service, Department of Radiology, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationSchool of Medicine - Faculty of Health, Deakin University, Waurn Ponds, Australiaen
dc.identifier.affiliationSouth Australian Health and Medical Research Institute, Adelaide, Australiaen
dc.identifier.affiliationThe University of Adelaide, Adelaide, Australiaen
dc.identifier.affiliationStroke Division, The Florey Institute of Neuroscience & Mental Health, University of Melbourne, Melbourne, Australiaen
dc.identifier.affiliationDepartment of Interventional Radiology - Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom..-
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.

Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.